Is Moderna Stock a Buy Following Pediatric Covid-19 Vaccine Data? Analyst Weighs In

197
Comment
Favorite

Is Moderna Stock a Buy Following Pediatric Covid-19 Vaccine Data? Analyst Weighs In

TipRanks2022-03-28

Competition for top dog billing in the Covid-19 vaccine space has basically turned into a two-horse race. So far, Pfizer (PFE)/BioNTech (BNTX)lead the way, but Moderna (MRNA)has provided the stiffest ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

197

Report

Comment

ZZX86
·2022-03-29
Awesomeeee！😆
Reply
1
Report
Tigon
·2022-03-28
🙂
Reply
2
Report
GggSlimeR
·2022-03-28
Let's buy Do not like my comment
Reply
1
Report
mster
·2022-03-28
As many countries have started opening up and easing regulations even for those non-vaccinated, I guess these vaccines companies may have already reach a plateau?
Reply
2
Report
bobbylim
·2022-03-28
Nice
Reply
2
Report
Taishu1234
·2022-03-28
hi
Reply
4
Report
Linglong8191
·2022-03-28
Like pls
Reply
3
Report
Tiongwee
·2022-03-28
Like
Reply
5
Report
Kenang
·2022-03-28
Pls like
Reply
6
Report
PBL77
·2022-03-28
Follow
Reply
4
Report
XiaTian
·2022-03-28
H
Reply
6
Report
Weeckee
·2022-03-28
I think a no
Reply
6
Report
gni
·2022-03-28
The companies have to make sure that the vaccine are truly safe for the children....
Reply
11
Report
TriciaChang
·2022-03-28
T
Reply
7
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1131407578?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-03-28 11:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131407578","market":"us","top_or_hot":-1,"title":"Is Moderna Stock a Buy Following Pediatric Covid-19 Vaccine Data? Analyst Weighs In","media":"TipRanks","content":"<div>\n<p>Competition for top dog billing in the Covid-19 vaccine space has basically turned into a two-horse race. So far, Pfizer (PFE)/BioNTech (BNTX)lead the way, but Moderna (MRNA)has provided the stiffest ...</p>\n\n<a href=\"https://www.tipranks.com/news/corona/is-moderna-stock-a-buy-following-pediatric-covid-19-vaccine-data-analyst-weighs-in/\">Source Link</a>\n\n</div>\n","source":"lsy1606183248679","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Moderna Stock a Buy Following Pediatric Covid-19 Vaccine Data? Analyst Weighs In</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Moderna Stock a Buy Following Pediatric Covid-19 Vaccine Data? Analyst Weighs In\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-28 11:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.tipranks.com/news/corona/is-moderna-stock-a-buy-following-pediatric-covid-19-vaccine-data-analyst-weighs-in/><strong>TipRanks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Competition for top dog billing in the Covid-19 vaccine space has basically turned into a two-horse race. So far, Pfizer (PFE)/BioNTech (BNTX)lead the way, but Moderna (MRNA)has provided the stiffest ...</p>\n\n<a href=\"https://www.tipranks.com/news/corona/is-moderna-stock-a-buy-following-pediatric-covid-19-vaccine-data-analyst-weighs-in/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"https://www.tipranks.com/news/corona/is-moderna-stock-a-buy-following-pediatric-covid-19-vaccine-data-analyst-weighs-in/","article_id":"1131407578","we_media_id":null,"thumbnails":[],"rights":{"source":"lsy1606183248679","url":"https://www.tipranks.com/news/corona/is-moderna-stock-a-buy-following-pediatric-covid-19-vaccine-data-analyst-weighs-in/","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1131407578","pubTimestamp":1648437989,"sourceInfo":{"source_id":"lsy1606183248679","name":"TipRanks"},"weMediaInfo":null,"summary":"Competition for top dog billing in the Covid-19 vaccine space has basically turned into a two-horse ","collect":0,"end_time":0,"defaultTopTitle":"tipranks.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"根据儿科新冠肺炎疫苗数据，莫德纳股票是买进的吗？分析师介入","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"Competition for top dog billing in the Covid-19 vaccine space has basically turned into a two-horse race. So far, Pfizer (PFE)/BioNTech (BNTX)lead the way, but Moderna (MRNA)has provided the stiffest competition. The latter vaccine maker has built its fortune on the success of its offering mRNA-1273 (Spikevax) and will attempt to get one over Pfizer/BioNTech’s product by being the first vaccine authorized for use in children under 6yrs old.Interim data from the KidCOVE trial showed that the one-quarter sized two-dose series resulted in a level of virus-blocking antibodies similar to that as the standard vaccine exhibited in adults age 18-25.In children aged 6 months to under 2 years, the vaccine showed an efficacy rate of 43.7% against omicron. In the older age group, the vaccine displayed efficacy of 37.5%. As there were no severe cases in the study, its efficacy against severe disease could not be evaluated.Based on the speed of past authorizations, Cowen analyst Tyler Van Buren says the data could lead to a US EUA “expansion” around April.Pfizer/BioNTech’s three-dose data are anticipated in April, and if positive, that could lead to an EUA extension around May. So, Moderna could get a head start on its competitor but how significant could that ultimately be?Van Buren thinks there could be a “small incremental advantage” though that is unlikely to change the overall revenue outlook for the year.In some states (New York, Vermont), where vaccine uptake in older children has been robust (over 80% in 5-11 age group), Van Buren thinks that in the month prior to Pfizer’s May entry, there could be “millions of doses administered.”But vaccine uptake for children across the US has generally been poor – less than 20% – and Van Buren expects demand to “level off quickly.”“As a result,” the analyst summed up, “we believe that most high-income countries have already accounted for a surplus of doses that should cover minors in existing or planned agreements, and these age expansions shouldn’t impact revenue significantly in the near term.”For now, the analyst remains on the sidelines with a Market Perform (i.e. Hold) rating, although his $200 price target could still generate returns of ~21% over the coming months.Looking at the consensus breakdown, based on 6 Buys, 7 Holds and 1 Sell, the analysts rate this name a Moderate Buy. The average price target is more bullish than Van Buren will allow; at $256.55, the figure indicates gains of ~55% could be in the cards over the next year.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":9019035854,"gmtCreate":1648487969451,"gmtModify":1676534344320,"author":{"id":"3583369953182365","authorId":"3583369953182365","name":"ZZX86","avatar":"https://static.tigerbbs.com/15d3e8593f7541d44903ad0cf41e2df2","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Awesomeeee！😆","listText":"Awesomeeee！😆","text":"Awesomeeee！😆","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9019035854","repostId":1131407578,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9019000532,"gmtCreate":1648480887217,"gmtModify":1676534343423,"author":{"id":"4096718719919660","authorId":"4096718719919660","name":"Tigon","avatar":"https://static.tigerbbs.com/2d2b0711d2de98150b8eae42253a8f8d","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"🙂","listText":"🙂","text":"🙂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9019000532","repostId":1131407578,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010488372,"gmtCreate":1648448580652,"gmtModify":1676534339203,"author":{"id":"4093058604760480","authorId":"4093058604760480","name":"GggSlimeR","avatar":"https://community-static.tradeup.com/news/4b805c8472adab6d9418f36452434a56","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":5,"crmLevelSwitch":1},"htmlText":"Let's buy&nbsp;Do not like my comment&nbsp;","listText":"Let's buy&nbsp;Do not like my comment&nbsp;","text":"Let's buy Do not like my comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010488372","repostId":1131407578,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010412135,"gmtCreate":1648446421276,"gmtModify":1676534339002,"author":{"id":"4102815868703010","authorId":"4102815868703010","name":"mster","avatar":"https://community-static.tradeup.com/news/81a8fe18bd419696551df5320d8db477","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"As many countries have started&nbsp;opening&nbsp;up and easing regulations even&nbsp;for those&nbsp;non-vaccinated, I guess these vaccines companies may have&nbsp;already&nbsp;reach a plateau?&nbsp;","listText":"As many countries have started&nbsp;opening&nbsp;up and easing regulations even&nbsp;for those&nbsp;non-vaccinated, I guess these vaccines companies may have&nbsp;already&nbsp;reach a plateau?&nbsp;","text":"As many countries have started opening up and easing regulations even for those non-vaccinated, I guess these vaccines companies may have already reach a plateau?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010412135","repostId":1131407578,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010411097,"gmtCreate":1648445464281,"gmtModify":1676534338946,"author":{"id":"3575499385722971","authorId":"3575499385722971","name":"bobbylim","avatar":"https://static.tigerbbs.com/1d9753dcafa04623c0e98c0bcaa291ae","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010411097","repostId":1131407578,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010432081,"gmtCreate":1648443740642,"gmtModify":1676534338516,"author":{"id":"3586770271918953","authorId":"3586770271918953","name":"Taishu1234","avatar":"https://static.tigerbbs.com/304c84abf6afa2a712e382db070e86df","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010432081","repostId":1131407578,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010438851,"gmtCreate":1648443449956,"gmtModify":1676534338477,"author":{"id":"4090106611802980","authorId":"4090106611802980","name":"Linglong8191","avatar":"https://static.tigerbbs.com/71a6ce91b1eb399b39912e57d7575d87","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010438851","repostId":1131407578,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010439533,"gmtCreate":1648442898116,"gmtModify":1676534338404,"author":{"id":"3573775111920367","authorId":"3573775111920367","name":"Tiongwee","avatar":"https://static.tigerbbs.com/e90910e406e67c77f42e225b16b69020","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010439533","repostId":1131407578,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010497911,"gmtCreate":1648442361377,"gmtModify":1676534338339,"author":{"id":"3578783239633074","authorId":"3578783239633074","name":"Kenang","avatar":"https://static.tigerbbs.com/9b932623d314153a412ec6160f17873c","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010497911","repostId":1131407578,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010495663,"gmtCreate":1648441895995,"gmtModify":1676534338315,"author":{"id":"4087190594214920","authorId":"4087190594214920","name":"PBL77","avatar":"https://static.tigerbbs.com/8ef4f93ba3e261ac276aef28c4467365","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Follow","listText":"Follow","text":"Follow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010495663","repostId":1131407578,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010498353,"gmtCreate":1648441041402,"gmtModify":1676534338208,"author":{"id":"3575368380492738","authorId":"3575368380492738","name":"XiaTian","avatar":"https://community-static.tradeup.com/news/71777f1a5ae276e73064272b5ae7df92","vip":1,"crmLevel":3,"crmLevelSwitch":1},"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010498353","repostId":1131407578,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010493530,"gmtCreate":1648440646906,"gmtModify":1676534338167,"author":{"id":"3582072953259355","authorId":"3582072953259355","name":"Weeckee","avatar":"https://static.itradeup.com/news/fa7604d9be05bbf456327176402c13a9","vip":1,"crmLevel":4,"crmLevelSwitch":1},"htmlText":"I think a no","listText":"I think a no","text":"I think a no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010493530","repostId":1131407578,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010404923,"gmtCreate":1648439200912,"gmtModify":1676534338072,"author":{"id":"3583162863775152","authorId":"3583162863775152","name":"gni","avatar":"https://static.tigerbbs.com/9bd2327989052e9257ef803c07e504e6","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"The companies have to make sure that the vaccine are truly safe for the children....&nbsp;","listText":"The companies have to make sure that the vaccine are truly safe for the children....&nbsp;","text":"The companies have to make sure that the vaccine are truly safe for the children....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010404923","repostId":1131407578,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9010406694,"gmtCreate":1648438428908,"gmtModify":1676534337940,"author":{"id":"3560421500323385","authorId":"3560421500323385","name":"TriciaChang","avatar":"https://static.tigerbbs.com/5cb6619edb253a8bb8b2776c7d9b0e02","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"T","listText":"T","text":"T","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9010406694","repostId":1131407578,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":197,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}